Magenta Therapeutics, Inc.·4

Nov 4, 4:39 PM ET

Mahoney Stephen F. 4

4 · Magenta Therapeutics, Inc. · Filed Nov 4, 2020

Insider Transaction Report

Form 4
Period: 2020-11-02
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-11-02+435,000435,000 total
    Exercise: $6.28Exp: 2030-11-01Common Stock (435,000 underlying)
Footnotes (1)
  • [F1]This option shall vest and become exerciseable over four years, with 25% of this option vesting on November 2, 2021, and the remainder vesting in 36 equal monthly installments thereafter.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION